Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.11.18 (
MAP
)
7,412
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The phosphoramidite monomer of the C-nucleoside 2'-aminoethoxy-2-amino-3-methylpyridine (AE-
MAP
) has been synthesized for the first time and incorporated into triplex-forming oligonucleotides (TFOs). Ultraviolet melting and
DNase I
footprinting studies show that AE-
MAP
is a potent triplex-stabilizing monomer that is selective for GC base pairs. TFOs containing AE-
MAP
bind with high affinity to duplexes but only weakly to single stranded DNA. In addition, AE-
MAP
confers high nuclease resistance on oligonucleotides. TFOs containing AE-
MAP
have potential for gene knock-out and gene expression studies.
...
PMID:2'-Aminoethoxy-2-amino-3-methylpyridine in triplex-forming oligonucleotides: high affinity, selectivity and resistance to enzymatic degradation. 2212 5